Bang第二天-BOA-China-AfterASCO.pptVIP

Standard Practice after ASCO 2009 Non-Colorectal Cancer Yung-Jue Bang Department of Internal Medicine Seoul National University Hospital Current Practice Advanced Gastric Cancer Doublets; Fluoropyrimidine + Platinum 5-FU infusion, capecitabine, S1 Cisplatin, oxaliplatin Triplets; Doulblet + Epirubicin or Docetaxel ECF, ECX, EOX DCF, modified DCF ASCO 2009TOGA: Efficacy results After ASCO 2009Advanced Gastric Cancer Patients with advanced gastric cancer should be tested for HER2 at diagnosis. Trastuzumab is a new treatment option for patients with HER2-positive advanced gastric cancer A